We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.72B
AUM Growth
-$123M
Cap. Flow
-$215M
Cap. Flow %
-7.9%
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Healthcare 12.35%
3 Industrials 12.24%
4 Technology 10.34%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARLO icon
1126
Arlo Technologies
ARLO
$1.51B
$163K 0.01%
46,486
-57,379
-55% -$236K
FRSG
1127
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$163K 0.01%
16,200
BLUE
1128
DELISTED
bluebird bio
BLUE
$162K 0.01%
+1,174
New +$165K
LXP icon
1129
LXP Industrial Trust
LXP
$3.52B
$162K 0.01%
3,236
-5,266
-62% -$263K
ELAN icon
1130
Elanco Animal Health
ELAN
$12.7B
$162K 0.01%
13,238
-133,169
-91% -$1.66M
PCYO icon
1131
Pure Cycle
PCYO
$260M
$160K 0.01%
+15,300
New +$143K
KRNL
1132
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$160K 0.01%
15,800
-5,400
-25% -$54.1K
HUMA icon
1133
Humacyte
HUMA
$182M
$157K 0.01%
74,392
+43,116
+138% +$131K
VMCA
1134
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
$157K 0.01%
+15,000
New +$154K
MTRY
1135
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
$157K 0.01%
+15,316
New +$157K
SHUA
1136
DELISTED
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
$157K 0.01%
15,200
-19,800
-57% -$202K
SSP icon
1137
E.W. Scripps
SSP
$271M
$155K 0.01%
+11,763
New +$162K
HMAC
1138
DELISTED
Hainan Manaslu Acquisition Corp. Ordinary shares
HMAC
$153K 0.01%
+15,000
New +$151K
FSRX
1139
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$153K 0.01%
+15,200
New +$151K
LBBB
1140
DELISTED
Lakeshore Acquisition II Corp. Ordinary Shares
LBBB
$153K 0.01%
+15,000
New +$152K
NMFC icon
1141
New Mountain Finance
NMFC
$649M
$153K 0.01%
+12,336
New +$152K
MSSA
1142
DELISTED
Metal Sky Star Acquisition Corporation Ordinary shares
MSSA
$152K 0.01%
14,980
-5,020
-25% -$50.4K
MNTX
1143
DELISTED
Manitex International, Inc.
MNTX
$152K 0.01%
+38,114
New +$176K
AIEV
1144
DELISTED
Thunder Power Holdings, Inc. Common Stock
AIEV
$152K 0.01%
+15,000
New +$151K
VRAY
1145
DELISTED
ViewRay, Inc.
VRAY
$152K 0.01%
34,013
-41,642
-55% -$181K
VOR icon
1146
Vor Biopharma
VOR
$1.05B
$152K 0.01%
1,143
-2,124
-65% -$210K
ALCE
1147
DELISTED
Alternus Clean Energy Inc
ALCE
$152K 0.01%
+600
New +$150K
CTSO icon
1148
Cytosorbents Corp
CTSO
$22.6M
$151K 0.01%
97,216
-80,287
-45% -$119K
ECDA
1149
DELISTED
ECD Automotive Design
ECDA
$150K 0.01%
+75
New +$150K
NRAC
1150
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$150K 0.01%
+14,805
New +$148K

Similar funds

Ergoteles's Q4 2022 Portfolio in Review

As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.

  • Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
  • Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
  • Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
  • Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
  • Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
  • Ergoteles opened 704 new positions and closed 800 in Q4 2022.
  • Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.